FDA panel: Pfizer boosters OK for high-risk groups
WASHINGTON (AP) --- An influential federal advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots to most Americans, but it endorsed the extra s…
WASHINGTON (AP) --- An influential federal advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots to most Americans, but it endorsed the extra s…